Currently, there are no established guidelines for treating XIAP deficiency and the only known curative therapy is allogeneic hematopoietic stem cell transplantation (HSCT), albeit with lower survival probabilities compared to the population eligible to be treated conservatively [5]. This evidence concerns the gene XIAP and hyperinsulinemic hypoglycemia, familial, 4.